IDEX Biometrics ASA
IDXAF
$0.89
$0.69345.00%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -69.80% | -83.95% | -87.73% | -82.48% | -79.69% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -69.80% | -83.95% | -87.73% | -82.48% | -79.69% |
| Cost of Revenue | -63.66% | -17.16% | -41.48% | -52.55% | -56.90% |
| Gross Profit | 57.53% | -261.54% | -756.69% | -2,561.54% | -461.80% |
| SG&A Expenses | -69.89% | -66.17% | -59.63% | -49.89% | -38.50% |
| Depreciation & Amortization | -80.97% | 12.58% | -44.69% | 35.54% | 53.94% |
| Other Operating Expenses | -27.50% | -8.30% | -16.45% | -20.56% | -16.64% |
| Total Operating Expenses | -54.33% | -36.86% | -37.42% | -31.54% | -26.59% |
| Operating Income | 53.74% | 33.98% | 32.83% | 24.98% | 18.41% |
| Income Before Tax | 31.07% | 29.05% | 63.63% | 46.47% | 45.32% |
| Income Tax Expenses | 65.83% | -1,058.82% | -1,458.33% | -490.00% | -700.00% |
| Earnings from Continuing Operations | 30.78% | 30.17% | 64.33% | 46.91% | 45.74% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 30.78% | 30.17% | 64.33% | 46.91% | 45.74% |
| EBIT | 53.74% | 33.98% | 32.83% | 24.98% | 18.41% |
| EBITDA | 49.18% | 38.56% | 36.74% | 34.05% | 27.33% |
| EPS Basic | 85.54% | 76.67% | 90.28% | 66.85% | 56.68% |
| Normalized Basic EPS | 97.78% | 78.52% | 91.49% | 68.03% | 53.14% |
| EPS Diluted | 85.68% | 76.93% | 90.68% | 68.62% | 57.97% |
| Normalized Diluted EPS | 97.78% | 78.51% | 91.46% | 67.92% | 52.95% |
| Average Basic Shares Outstanding | 803.43% | 635.67% | 317.42% | 81.28% | 36.13% |
| Average Diluted Shares Outstanding | 802.56% | 634.24% | 316.33% | 80.77% | 35.68% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |